NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 45 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $102,000 | -89.3% | 259,441 | -71.4% | 0.03% | -91.1% |
Q2 2022 | $952,000 | -44.1% | 906,445 | 0.0% | 0.36% | -36.5% |
Q1 2022 | $1,704,000 | -33.1% | 906,445 | 0.0% | 0.56% | -26.6% |
Q4 2021 | $2,547,000 | -22.2% | 906,445 | 0.0% | 0.77% | -26.4% |
Q3 2021 | $3,272,000 | -21.4% | 906,445 | +4.3% | 1.04% | +0.9% |
Q2 2021 | $4,161,000 | +43.0% | 868,699 | +120.7% | 1.03% | +75.3% |
Q1 2021 | $2,909,000 | +41.7% | 393,699 | +34.0% | 0.59% | +40.5% |
Q4 2020 | $2,053,000 | -11.1% | 293,699 | -3.5% | 0.42% | -8.1% |
Q3 2020 | $2,310,000 | +46.7% | 304,376 | +69.7% | 0.46% | -0.7% |
Q2 2020 | $1,575,000 | – | 179,404 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
CM Management, LLC | 450,000 | $178,000 | 0.20% |
Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |